Alexandria Real Estate Equities I.../ US0152711091 /
3/24/2023 8:59:52 PM | Chg. +3.82 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
119.85USD | +3.29% | 69,658 Turnover: 8.17 mill. |
-Bid Size: - | -Ask Size: - | 20.75 bill.USD | 3.94% | 37.69 |
GlobeNewswire
2/23/2022
Intellia Therapeutics Enters Lease Agreement to Build Manufacturing Facility for its CRISPR-based Th...
GlobeNewswire
10/21/2021
Orange Grove Bio, AlleyCorp and Alexandria Venture Investments Establish Partnership with Albert Ein...
GlobeNewswire
9/21/2021
Adaptive Biotechnologies Announces Grand Opening of State-of-the-Art Headquarters and Expands Footpr...
GlobeNewswire
5/13/2021
TCR² Therapeutics Reports First Quarter 2021 Financial Results and Provides Corporate Update
GlobeNewswire
3/29/2021
TCR² Therapeutics Establishes Commercial-Scale Cell Therapy Manufacturing Facility
GlobeNewswire
2/24/2021
Life Science Cares and Biogen Foundation Help Launch Food For Free’s Just Eats Program
GlobeNewswire
8/12/2020
Beam Therapeutics Announces First Development Candidates for Sickle Cell Disease and Reports Second ...
GlobeNewswire
11/14/2019
Sarepta and StrideBio Announce Multi-target Strategic Collaboration to Advance Novel Gene Therapies
GlobeNewswire
8/7/2019
Adaptive Biotechnologies Executes Lease for New 100,000 Square Foot Corporate Headquarters, Tripling...
GlobeNewswire
4/10/2019
Research Report Identifies Ringcentral, The Walt Disney, MDC Partners, Alexandria Real Estate Equiti...
GlobeNewswire
2/20/2019
Consolidated Research: 2019 Summary Expectations for Delta Air Lines, Alexandria Real Estate Equitie...
GlobeNewswire
2/19/2019
CRISPR Therapeutics and StrideBio Expand Exclusive Development and Option Agreement